Vivos Therapeutics
VVOS
VVOS
23 hedge funds and large institutions have $2.13M invested in Vivos Therapeutics in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 4
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$620K | |
| 2 | +$310K | |
| 3 | +$151K | |
| 4 |
DS
DRW Securities
Chicago,
Illinois
|
+$129K |
| 5 |
Renaissance Technologies
New York
|
+$122K |
Top Sellers
| 1 | -$442K | |
| 2 | -$80.6K | |
| 3 | -$64.9K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$14.3K |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$234 |
